Depression in Parkinson's disease as the key factor of deterioration in quality of life: pathophysiology, diagnostics and treatment
https://doi.org/10.21518/2079-701X-2013-4-36-41
Abstract
Parkinson's disease (PD) is multisystem neurodegenerative disorder with a wide range of motor, nervous and mental disorders. On average, depression occurs in 40-50% of patients with Parkinson's disease and is a major factors of deterioration of life quality. The article tells about present-day knowledge about the disease pattern, pathophysiology and approaches to the treatment of depression in Parkinson's disease.
About the Author
M. R. Nodel
the First Moscow State Medical University named after I.M.Sechenov
Russian Federation
Russian Federation
References
1. Яхно Н.Н. Невропсихиатрия. Место неврологов. X Всероссийский съезд неврологов с международным участием // Материалы съезда. Н. Новгород, 2012. С. 698.
2. Яхно Н.Н. Захаров В.В., Нодель М.Р. Когнитивные и другие нервно-психические нарушения болезни Паркинсона // Болезни движений: медицинские и социальные аспекты / под ред. Е.И. Гусева, А.Б. Гехт. М., 2010. С. 95–97.
3. Нодель М.Р., Яхно Н.Н. Нервно-психические нарушения болезни Паркинсона // Неврология. Нейропсихиатрия. Психосоматика. 2009. №2. C. 3–8.
4. Нодель М.Р. Недвигательные нарушения болезни Паркинсона // Доктор.Ру. Неврология. 2009. №4. C. 12–16.
5. Левин О.С. Болезнь Паркинсона как нейропсихиатрическое заболевание: Руководство для врачей по материалам II Национального конгресса по болезни Паркинсона и расстройствам движений / под ред. С.Н. Иллариошкина, О.С. Левина. М., 2011. С. 99–104.
6. Нодель М.Р. Клинические особенности и лечение недвигательных нарушений болезни Паркинсона // Медицинский совет. 2012. №4. С. 30–36.
7. Aarsland D., Marsh L., Schrag А. Neuropsychiatric symptoms in Parkinsons Disease // Mov.Dis. 2009. Vol. 24(15). P. 2175–86.
8. O’Sullivan S.S., Williams D.R., Gallarher D.A. et al. Non motor symptoms as presenting complaints in Parkinsons disease: a clinicopathological study // Mov. Dis. 2008. Vol. 23. P. 101–106.
9. Shrag A., Jahanshahi M., Quinn N.P. What contributes to quality life in patients with Parkinsons disease? // J. Neurol. Neurosurg. Neuropsych. 2000. Vol. 69. P. 308–312.
10. Scaravilli T., Gasparoli E., Rinaldi F. et al. Health related quality of life in Parkinsons disease // J. Nourol. Neurosurg. Psychiat. 2003. №74 (2). P. 163–169.
11. McKinlay A., Grace R.C., Dalrymple-Alford J.C. et al. A profile of neuropsychiatric problems and their relationship to quality of life for Parkinsons disease // Park. and Relat. disord. 2008. Vol. 14. P. 37–42
12. Cole S.A., Woodard J.L., Juncos J.L. et al. Depression and disability in Parkinsons disease // J. Neuropsychiatry Clin. Neurosci. 1996. Vol. 8. P. 20–25.
13. Shrag A., Jahanshahi M., Quinn N.P. What contributes to depression in Parkinsons disease? // Psychol. Med. 2001. Vol. 31. P. 65–73.
14. Starkstein S.E., Preziosi T.J., Robinson R.G. Sleep disorders, pain and Parkinsons disease depression in Parkinsons disease // Eur. Neurol. 1991. Vol. 31(6). P. 352–355.
15. Norman S., Troster A.I., Fields J.A. et al. Effects of depression and Parkinsons disease on cognitive functioning // J. Neuropsychiatr. Clin. Neurosci. 2002. Vol. 14(1). P. 31–36.
16. Нодель М.Р. Депрессия при болезни Паркинсона // Неврология. Нейропсихиатрия. Психосоматика. 2010. №4. C. 11–17. Полный список литературы вы можете запросить в редакции.
17. Левин О.С. Болезнь Паркинсона как нейропсихиатрическое заболевание. //Руководство для врачей по материалам II Национального конгресса по болезни Паркинсона и расстройствам движений (под ред. С.Н. Иллариошкина, О.С. Левина). М. 2011. С.99–104.
18. М.Р. Нодель. Клинические особенности и лечение недвигательных нарушений болезни Паркинсона.// Медицинский совет. -2012.-N 4.-С.30-36.
19. D.Aarsland, Marsh L., A.Schrag . Neuropsychiatric symptoms in Parkinsons Disease. //Mov.Dis.-2009- Vol.24(15).-P.2175-86.
20. OSullivan S.S., Williams D.R., Gallarher D.A., et,.al. Non motor symptoms as presenting complaints in Parkinsons disease: a clinicopathological study. //Mov.Dis.-2008-Vol.23-P.101-106.
21. Shrag A., Jahanshahi M., Quinn N.P. What contributes to quality life in patients with Parkinsons disease?//J.Neurol.Neurosurg.Neuropsych.-2000.-Vol.69.-P.308-312.
22. Scaravilli T., Gasparoli E., Rinaldi F. et.al. Health related quality of life in Parkinsons disease. // J.Nourol.Neurosurg.Psychiat.-2003.-74 (2)-P.163-169.
23. Mc Kinlay A., Grace R.C., Dalrymple-Alford J.C., et.al. A profile of neuropsychiatric problems and their relationship to quality of life for Parkinsons disease. //Park. and Relat. disord.-2008.-Vol.14.-P.37-42
24. Cole S. A., Woodard J. L. , Juncos J. L. , et. al. Depression and disability in Parkinsons disease. // J. Neuropsychiatry Clin. Neurosci. -1996. - Vol. 8. - P. 20-25.
25. Shrag A., Jahanshahi M., Quinn N.P. What contributes to depression in Parkinsons disease?// Psychol.Med.-2001.-Vol.31.-P.65-73.
26. S.E.Starkstein, Preziosi T.J., Robinson R.G. Sleep disorders, pain and Parkinsons disease depression in Parkinsons disease. //Eur. Neurol.-1991.-Vol.31(6).-P.352-355.
27. Norman S., Troster A.I., Fields J.A., et.al. Effects of depression and Parkinsons disease on cognitive functioning. . // J.Neuropsychiatr.Clin. Neurosci.-2002.-Vol.14(1).-P.31-36.
28. М.Р. Нодель. Депрессия при болезни Паркинсона. //Неврология.
29. Нейропсихиатрия.Психосоматика.-2010.-N4.- C.11-17.
30. Dooneief G., Mirabello E., Bell K., et.al. An estimate of the incidence of depression in idiopathic Parkinsons disease. //Arch.Neurol.-1992.-Vol.49(3).-P.305-307.
31. Lemke M.R. Depressive symptoms in Parkinsons disease. //Eur. J.of Neurol.-2008.-Vol.15(Suppl.1).-P.21-25.
32. Gotham A. M., Brown R. C. , Marsden C. D. Depression in Parkinsons disease: a quantitative and qualitative analysis in Parkinsons disease. // J. Neuropsychiatry Clin. Neurosci. -1996. - Vol. 8. - P. 20-25.
33. Mayberg H.S., Starkstein S.E., Sadzot B., et.al. Selective hypometaboloism in the inferior frontal lobe in depressed patients with Parkinsons Disease. //Ann.Neurol.-1990.-Vol.28(1)-P.57-64.
34. Matsiu H., Nishinaka K., Oda M., et.al. Depression in Parkinsons disease:diffusion tensor imaging study. //J.Neurol.-2007.-Vol.254.-P.1170-1173.
35. Chaudhuri K.R., Schapira A. H.V. Non-motor symptoms of Parkinsons disease: dopaminergic pathophysiology 23. R.Mayeux, Y.Stern, I.Cote , J.B. Williams. Altered serotonin metabolism in depressed patients with Parkinsons Disease. //Neurol.-1984.-Vol.34(5).-P.642-646.
36. M.Yamomoto. Depression in Parkinsons Disease : its prevalence, diagnosis, and neurochemical background. //J.Neurol.-2001.-Vol.248 (Suppl
37. P.G.Frisina, V.Haroutunian, L.S.Libow. The neuropatological basis for depression in Parkinsons Disease. //Park. and Relat.Dis.-2009.-Vol.15.-P.144-148.
38. Remy P., M.Doder, A.Lees, et.al. Depression in Parkinsons Disease: loss of dopamine and noradrenaline innervation in the limbic system. //Brain.-2005.-Vol.128.-P.1314-1322.
39. M.Guttman, M.Torti, J.Warsh et.al. Are brain serotonin transporter levels decreased in depressed patients with Parkinsons Disease? //J.Neurol.Sci-2006.-Vol.248-P.299.
40. Alex K.D., Pehek E.A. Pharmacologic mechanisms of serotoninergic regulation of dopamine neurotransmission. // Pharmacol. Ther.-2007.-Vol.113-P.296-320.
41. F.Fang, Q.Xu, Y.Park, X.Huang, et.al. Depression and the subsequent risk of Parkinsons disease in the NIN-AARP Diet and Health Study. //Mov.Dis.-2010-Vol.25.-N9.-P.1157-1162.
42. Braak H., Del Tredici K., Rub U., et. al. Staging of brain pathology related to sporadic Parkinsons disease. //Neurology Aging - 2003.-Vol.24.-P.197-210.
43. Santamaria J. , Tolosa E. , Valles A. Parkinsons disease with depression: a possible subgroup of idiopathic parkinsonism. //Neurology. -1986. - Vol. 36. - P. 1130-1133.
44. A.F.Leentjens, R.Lousberg, F.R.Verhey. Markers for depression in Parkinsons Disease. //Acta Psych.Scand.-2002.-Vol.106(3)-P.196-201.
45. Cummings J. L. Depression and Parkinsons disease: a review. // Am. J. Psychiatry-1992. - Vol. 149. - P. 443-454.
46. E.Tanberg, J.P.Larsen, D.Aarsland et.al. Risk factors for depression in Parkinsons Disease. //Arch. Neurol.-1997.-Vol.54(5).-P.625-630.
47. A.Rojo , M.Agullar , M.T. Garolera , et.al. Depression and Parkinsons disease: clinical correlates and outcome. //Park. Relat Dis.- 2003.-Vol.10(1).-P.23-28.
48. Cole S.A., Woodard J.L., Juncos J.L., et.al. Depression and disability in Parkinsons disease. //J.Neuropsychiatr.Clin. Neurosci-1996.-Vol.8(1).-P.20-25.
49. C.Becker, G.P.Brobert, S.Johansson et.al. Risk of incident depression in patients with Parkinsons disease in the UK. //Eur.J.of Neurol.-2011.-Vol.18.-P.448-453.
50. A.Althaus, O.A.Becker, A.Spottke, et.al. Frequency and treatment of depressive symptoms in a Parkinsons Disease registry. //Park. and Relat. disord.-2008.-Vol.14.-P.626-632
51. Y.Cheng, C.Liu, C.Mao et.al. Social support plays a role in depression in Parkinsons disease: a cross-section study in a Chinese cohort. //Park. аnd Related Dis.-2008.-Vol.14.-P.43-45.
52. Янакаева Т. А. Сравнительный анализ когнитивных и аффективных расстройств при дисциркуляторной энцефалопатии, болезни Паркинсона и болезни Альцгеймера. Диссертация …канд. мед. наук. – М., 1999.
53. E.Starkstein, Petracca G., Chemerinski E., et.al. Depression in classic versus akinetic-rigid Parkinsons disease. //J.Neur. Ment.Dis.-1998.-Vol.13(1).P.-29-33.
54. F.Liebermann. Depression in Parkinsons Disease- a review. //Acta Neurol.Scand.-2006.-Vol.113-P.1-8.
55. Lemke M.R. Depressive symptoms in Parkinsons disease. //Eur.J.of Neurol.-2008.-Vol.15(Suppl.1).-P.21-25.
56. American Psychiatric Association. Diagnostic and Statistical Manual of mental Disorders, 4-th ed. Washington, ВС:APA Press 2000.
57. J.Reiff, N.Schmidt, B.Riebe, et.al. Subthreshold depression in Parkinsons disease. //Mov.Dis.-2011-Vol.26-N9.-P.1741-1744.
58. S.E.Starkstein , M.Merello, R.Jorge , et.al. A validity study of depressive syndromes in Parkinsons disease. // Mov.Dis.-2008-Vol.23-P.538-546.
59. T.Inoue, M.Kitagawa, T.Tanaka, et.al. Depression and major depressive disorder in patients with Parkinsons disease. // Mov.Dis.-2010-Vol.25-N1-P.44-49.
60. Barone P., Antonini A., Colosimo C., et.al. The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson disease. //Mov.Dis.-2009.-Jun 9.-P.215-216.
61. Shrag A., Barone P., Brown R.G. et.al. Depression rating scales in Parkinson disease: critique and recommendations. //Mov.Dis.-2007.-Vol.22.-P.1077-1192.
62. Dujardin K., Sockeel P., Devos D., et.al. Characteristic of apathy in Parkinsons disease. // Mov.Dis.-2007.-Vol.22.-P.778-784.
63. М.Р. Нодель. Утомляемость при болезни Паркинсона и ее коррекция агонистом дофаминовых рецепторов прамипексолом //Неврология. Нейропсихиатрия.Психосоматика.-2011.-N 4.- C.22-26.
64. Barone P et al. Depression and antidepressant use in Parkinson’s disease: Results from the PRODEST-PD study. Abstract P1122 poster presented at 11th Congress of EFNS, Brussels, 26 Aug 2007.
65. Weintraub D., Morales K.H., Moberg P.J., et.al. Antidepressant studies in Parkinsons disease: a review and meta-analysis. // Mov.Dis.-2005.-Vol.20.-P.1161-1169.
66. Miyasaki J.M., Shannon K., Voon V., et.al. Practice parameter: evaluation and treatment of depression, psychosis and dementia in Parkinsons disease (an evidence-based review):report of the Quality Standards Subcommittee of the American Academy of Neurology. //Neurol.-2006.-Vol.66.-P.996-1002.
67. Devos D., Dujardin K., Poirot I., et.al. Comparison of desipramine and citalopram treatments with depression in Parkinsons disease: a double-blind placebo-controlled study. //Mov.Dis.-2008.-Vol.23.-P.850-7.
68. I.H.Richard, M.P.McDermott, R.Kurlan et.al. A randomized, double –blind, placebo-controlled trial of antidepressants in Parkinsons disease. //Neurol.-2012-Vol.11-N9.-P.26-34.
69. Menza M., Dobkin R.D., Marin H., et.al. A controlled trial of antidepressants in patients with Parkinsons disease and depression. //Neurol.-2009.-Vol.72.-P.886-92
70. Mann J. J., Kapur S. A dopaminergic hypothesis of major depression. // Clin. Neuropharmacol. -1996. -Vol. 18(suppl. 1). -P. 57-65.
71. Barbeu A. L. L-Dopa therapy in Parkinson disease: a critical review of nine years experience. // J. Can. Med. Assoc. -1969. -Vol. 101. -P. 791-800.
72. Нодель М.Р., Артемьев Д.В., Яхно Н.Н.. Эффективность дофаминового агониста Мирапекса при болезни Паркинсона. // Неврологический журнал. - 1999. – N6. - С. 45-49.
73. Левин О.С., Федорова Н.В., Смоленцева И.Г. Применение агонистов дофаминовых рецепторов при болезни Паркинсона.//Неврологический журнал- 2002. -№1. С.41-45.
74. Lemke M.P., Brecht H.M., Koester J.K., et.al. Anhedonia, depression, and motor functioning in Parkinsons disease during treatment with Pramipexole. //J.Neuropsych.Clin.Neurosci-2005.-Vol.17.-P.2.-P.214-220.
75. Barone P., Poewe W., Tolosa E., et.al. Efficacy of double-blind, placebo-controlled pramipexole against depression in Parkinsons disease. Abstracts of the Movement Disorders Societys Thirteenth International Congress of Parkinson's disease and movement disorders. June 7-11-2009-Suppl.1 –P.291.
76. Schoenfeld M.A., Pantelie C.M., B. Schwartz . Clinical criteria for the switch of treatment strategies in Parkinson’s disease. //Clinical Neurol. and Neurosurg. -2003.-Vol. 105.-P.241-244.
Review
For citations:
Nodel MR. Depression in Parkinson's disease as the key factor of deterioration in quality of life: pathophysiology, diagnostics and treatment. Meditsinskiy sovet = Medical Council. 2013;(4):36-41. (In Russ.) https://doi.org/10.21518/2079-701X-2013-4-36-41
Views:
677
Email this article 